Andrew Harmon, MBAManager, Life Sciences Strategy Consulting at Sia PartnersSpeaker
Profile
Mr. Harmon is a Manager at Sia/LBG with 14 years of experience across life-science strategy, finance, and operations, focused on the economics and capacity dynamics shaping advanced therapeutics. He specializes in quantitative market analysis, including industry-referenced supply-and-demand models that assess manufacturing constraints and modality-specific capacity needs. He also advises industry and government stakeholders on investment priorities, growth strategy, and ecosystem development, with recent work supporting national public-health initiatives and broader life-science capacity building in the Middle East. He speaks internationally on manufacturing bottlenecks, financing barriers, and the market dynamics shaping advanced therapeutics.
Agenda Sessions
Panel Discussion – The Next Decade in Biomanufacturing Strategy
, 4:45pmView SessionInvestment Trends Shaping the Next Wave of Cell and Gene Therapy: Outlook and Challenges
, 3:45pmView Session
